CN1066728C - 生产环氧化物的方法 - Google Patents
生产环氧化物的方法 Download PDFInfo
- Publication number
- CN1066728C CN1066728C CN95192714A CN95192714A CN1066728C CN 1066728 C CN1066728 C CN 1066728C CN 95192714 A CN95192714 A CN 95192714A CN 95192714 A CN95192714 A CN 95192714A CN 1066728 C CN1066728 C CN 1066728C
- Authority
- CN
- China
- Prior art keywords
- formula
- epoxide
- solvent
- monovalent
- halohydrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Description
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20607494A | 1994-03-04 | 1994-03-04 | |
US08/206,074 | 1994-03-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1146768A CN1146768A (zh) | 1997-04-02 |
CN1066728C true CN1066728C (zh) | 2001-06-06 |
Family
ID=22764868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95192714A Expired - Lifetime CN1066728C (zh) | 1994-03-04 | 1995-02-27 | 生产环氧化物的方法 |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0748319B1 (zh) |
JP (1) | JP3871705B2 (zh) |
KR (1) | KR100387741B1 (zh) |
CN (1) | CN1066728C (zh) |
AT (1) | ATE210662T1 (zh) |
AU (1) | AU690231B2 (zh) |
BR (1) | BR9506977A (zh) |
CA (1) | CA2183976C (zh) |
CZ (1) | CZ291816B6 (zh) |
DE (1) | DE69524578T2 (zh) |
DK (1) | DK0748319T3 (zh) |
ES (1) | ES2167419T3 (zh) |
FI (1) | FI120259B (zh) |
HR (1) | HRP950096B1 (zh) |
HU (1) | HU222750B1 (zh) |
MX (1) | MX9603871A (zh) |
NZ (1) | NZ281866A (zh) |
PT (1) | PT748319E (zh) |
RO (1) | RO117696B1 (zh) |
RU (1) | RU2137769C1 (zh) |
SK (1) | SK283067B6 (zh) |
TW (1) | TW380137B (zh) |
UA (1) | UA45968C2 (zh) |
WO (1) | WO1995023797A1 (zh) |
YU (1) | YU49010B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728840A (en) * | 1994-03-04 | 1998-03-17 | Merck & Co., Inc. | Process for making an epoxide |
TW415948B (en) * | 1995-10-30 | 2000-12-21 | Merck & Co Inc | Process for synthesizing epoxide and halohydrin |
US5981759A (en) * | 1997-06-20 | 1999-11-09 | Merck & Co., Inc. | Process for indinavir intermediate |
CN105237621A (zh) | 2005-11-09 | 2016-01-13 | 欧尼斯治疗公司 | 用于酶抑制的化合物 |
EP2041158B1 (en) | 2006-06-19 | 2013-04-17 | Onyx Therapeutics, Inc. | Peptide epoxyketones for proteasome inhibition |
CL2008002966A1 (es) | 2007-10-04 | 2010-06-25 | Onyx Therapeutics Inc | Compuesto tetrapeptido ceto-epoxido cristalino; sal citrato cristalina del compuesto; metodos de preparacion; compuesto intermediario cristalino; metodo de preparacion; y uso para tratar cancer, enfermedad autoinmune, afeccion relacionada con trasplante, enfermedad neurodegenerativa, afeccion asociada con fibrosis, entre otros. |
EA035100B1 (ru) | 2008-10-21 | 2020-04-28 | Оникс Терапьютикс, Инк. | Комбинированная терапия с применением пептид эпоксикетонов |
TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
WO2011060179A1 (en) | 2009-11-13 | 2011-05-19 | Onyx Therapeutics, Inc | Use of peptide epoxyketones for metastasis suppression |
US9359398B2 (en) | 2010-03-01 | 2016-06-07 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
BR112012027901A2 (pt) * | 2010-04-30 | 2015-09-08 | Univ Indiana Res & Tech Corp | processos para preparar linezolida |
UY34897A (es) | 2012-07-09 | 2014-01-31 | Onyx Therapeutics Inc | Profarmacos de inhibidores peptidicos de expoxi cetona proteasa |
CN104692987B (zh) * | 2015-01-22 | 2017-05-17 | 北京大学 | 卤代醇及其衍生物的廉价高效合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2072237A1 (en) * | 1991-07-02 | 1993-01-03 | Merck & Co., Inc. | Stereoselective production of hydroxyamide compounds from chiral -amino epoxides |
EP0541168B1 (en) * | 1991-11-08 | 1998-03-11 | Merck & Co. Inc. | HIV protease inhibitors useful for the treatment of aids |
-
1995
- 1995-02-24 TW TW084101733A patent/TW380137B/zh not_active IP Right Cessation
- 1995-02-27 DE DE69524578T patent/DE69524578T2/de not_active Expired - Lifetime
- 1995-02-27 CA CA002183976A patent/CA2183976C/en not_active Expired - Fee Related
- 1995-02-27 JP JP52294995A patent/JP3871705B2/ja not_active Expired - Fee Related
- 1995-02-27 EP EP95911105A patent/EP0748319B1/en not_active Expired - Lifetime
- 1995-02-27 NZ NZ281866A patent/NZ281866A/en not_active IP Right Cessation
- 1995-02-27 SK SK1122-96A patent/SK283067B6/sk not_active IP Right Cessation
- 1995-02-27 MX MX9603871A patent/MX9603871A/es unknown
- 1995-02-27 RO RO96-01750A patent/RO117696B1/ro unknown
- 1995-02-27 HU HU9602412A patent/HU222750B1/hu not_active IP Right Cessation
- 1995-02-27 RU RU96120179A patent/RU2137769C1/ru not_active IP Right Cessation
- 1995-02-27 DK DK95911105T patent/DK0748319T3/da active
- 1995-02-27 KR KR1019960704836A patent/KR100387741B1/ko not_active IP Right Cessation
- 1995-02-27 CZ CZ19962543A patent/CZ291816B6/cs not_active IP Right Cessation
- 1995-02-27 BR BR9506977A patent/BR9506977A/pt not_active IP Right Cessation
- 1995-02-27 AT AT95911105T patent/ATE210662T1/de active
- 1995-02-27 PT PT95911105T patent/PT748319E/pt unknown
- 1995-02-27 WO PCT/US1995/002347 patent/WO1995023797A1/en active IP Right Grant
- 1995-02-27 UA UA96103798A patent/UA45968C2/uk unknown
- 1995-02-27 AU AU18828/95A patent/AU690231B2/en not_active Ceased
- 1995-02-27 ES ES95911105T patent/ES2167419T3/es not_active Expired - Lifetime
- 1995-02-27 CN CN95192714A patent/CN1066728C/zh not_active Expired - Lifetime
- 1995-03-02 HR HR950096A patent/HRP950096B1/xx not_active IP Right Cessation
- 1995-03-03 YU YU14595A patent/YU49010B/sh unknown
-
1996
- 1996-09-03 FI FI963452A patent/FI120259B/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1066728C (zh) | 生产环氧化物的方法 | |
CN1759093A (zh) | 用于制备1,2-二氨基化合物的不使用叠氮化物的方法 | |
KR20110066224A (ko) | Hiv 인테그라제 억제제 | |
CN1043042C (zh) | 7-[2-(2-氨基噻唑-4-基)-2-(Z)-羟亚胺基-乙酰胺基]-3-(甲氧甲基)-3-头孢烯-4-羧酸-α-(2,2-二甲基丙酰氧)乙酯拆分的方法 | |
CN1099387A (zh) | β-氨基醇的制备方法 | |
CN1066723C (zh) | Hiv蛋白酶抑制剂的中间体及其制备方法 | |
CN1083425C (zh) | 由环氧化物制备顺式-1-氨基-2-链烷醇的区域专一性方法 | |
CN1247591C (zh) | 吲哚衍生物及其医药应用 | |
CN1252788A (zh) | 制备药用化合物的方法 | |
CN1130905A (zh) | Hiv蛋白酶抑制剂的制备方法 | |
CN1077881C (zh) | 由二醇或卤代醇制备顺式-1-氨基-2-链烷醇的区域专一性方法 | |
CN1100054C (zh) | 由(2s)-4-吡啶甲基-2-哌嗪-叔丁基甲酰胺制备hiv蛋白酶抑制剂的方法 | |
US5728840A (en) | Process for making an epoxide | |
CN1041731C (zh) | 吡啶并[1,2,3—d,e][1,3,4]苯并噁二嗪衍生物 | |
CN1514825A (zh) | 可用于反流病的新化合物 | |
CN1774441A (zh) | 7-[2-(2-氨基噻唑-4-基)-2-羟基亚氨基乙酰胺]-3-乙烯基-3-头孢烯-4-羧酸(顺式异构体)的新型晶体和其制备方法 | |
US6649761B2 (en) | Process for preparing piperazinepentaneamide HIV protease inhibitors | |
CN1122669C (zh) | 8H-噻吩并[2,3-b]吡咯嗪-8-酮化合物,其制备方法以及含有它们的药物组合物 | |
CN1183780A (zh) | 用于制备n-(2-(r)-羟基-1-(s)-2,3-二氢化茚基)-2-(r)-苯甲基-4(s)-羟基-5-(1-(4-(3-吡啶甲基)-2(s)-n′-(叔丁基甲酰氨基)哌嗪基)戊酰胺(二化合物丁或l-735,524)的还原性烷基化方法 | |
JP2014125458A (ja) | 光学活性ベンズアミド誘導体の製造方法 | |
CN1290247A (zh) | 制备抗叶酸剂的方法和中间体 | |
CN1164531A (zh) | 3-溴-和3,3-二溴-4-氧代-1-氮杂环丁烷新衍生物、其制备方法及其它们的用途 | |
JP2005047874A (ja) | Hivに有効な新規ジペプチド化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1001295 Country of ref document: HK |
|
C56 | Change in the name or address of the patentee |
Owner name: MERCK + CO INC Free format text: FORMER NAME: MIKE COMPANY |
|
CP01 | Change in the name or title of a patent holder |
Address after: New Jersey, USA Patentee after: Schering Corporation Address before: New Jersey, USA Patentee before: MERCK & Co.,Inc. |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20150227 Granted publication date: 20010606 |